|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-11-2
|
|
pubmed:abstractText |
To assess the safety and effectiveness of treating high-risk T1 and T2 bladder cancer with transurethral resection (TUR-BT) followed by radiochemotherapy (RCT) combined with regional deep hyperthermia (RHT).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1879-0887
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
93
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
358-63
|
|
pubmed:meshHeading |
pubmed-meshheading:19837472-Adult,
pubmed-meshheading:19837472-Aged,
pubmed-meshheading:19837472-Aged, 80 and over,
pubmed-meshheading:19837472-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19837472-Combined Modality Therapy,
pubmed-meshheading:19837472-Female,
pubmed-meshheading:19837472-Humans,
pubmed-meshheading:19837472-Hyperthermia, Induced,
pubmed-meshheading:19837472-Male,
pubmed-meshheading:19837472-Middle Aged,
pubmed-meshheading:19837472-Neoplasm Metastasis,
pubmed-meshheading:19837472-Neoplasm Recurrence, Local,
pubmed-meshheading:19837472-Quality of Life,
pubmed-meshheading:19837472-Salvage Therapy,
pubmed-meshheading:19837472-Urinary Bladder Neoplasms
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia.
|
|
pubmed:affiliation |
Department of Radiooncology, University of Erlangen, Germany. michael.wittlinger@uk-erlangen.de
|
|
pubmed:publicationType |
Journal Article
|
